Please login to the form below

Incivek

This page shows the latest Incivek news and features for those working in and with pharma, biotech and healthcare.

Access to new hep C treatments put under the spotlight

It can also be used in patients with advanced liver disease and who have failed prior treatment with HCV protease inhibitors such as Merck &Co's Victrelis (boceprevir) and Vertex' Incivek

Latest news

FDA approves four new medicines across multiple areas

and Vertex' Incivek (telaprevir).
J&J starts to feel biosimilar competition bite

toll on J&J's Olysio (simeprevir) and Incivek (telaprevir) products.
Top biotech firms saw sales jump in 2014

Dion added: “This drop was largely attributable to sliding sales of Incivek (telaprevir), Vertex's hepatitis C virus protease inhibitor, which fell by $442.3m compared with 2013, primarily as a
The end of hepatitis C?

The launch a few years ago of first-generation protease inhibitors to the pharmaco-therapeutic arsenal - Vertex' Incivek (telaprevir) and Merck &Co's Victrelis (boceprevir) - drastically improved success rates in some
BMS can ride on Sovaldi's success as Daklinza cleared in EU

patients with advanced liver disease and who have failed prior treatment with HCV protease inhibitors such as Merck &Co's Victrelis (boceprevir) and Vertex' Incivek (telaprevir).

More from news
Approximately 0 fully matching, plus 23 partially matching documents found.

Latest from PMHub

Warehousing of HCV patients reaches new high

New drugs from Vertex (Incivek) and Merck (Victrelis) have been welcomed because they are more effective, but they still need to be given with Interferon.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Global Business Development Director – Health Education: excellent commission

Senior Account Manager, Rare Diseases – Medical Communications, ...: Excellent package

Account Director – Health Policy – Global Agency: Salary TBC

Account Director: Competitive Salary Offered

Account Manager / Senior Account Manager: 35, 000-40, 000

Account Director, Healthcare Marketing Agency: Salary TBC

Engagement Expert, Healthcare Brand Communications, London: Excellent package

Account Director, Medical Education: Salary TBC

Business Director: Competitive Salary Offered

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Senior Medical Writer: Salary TBC

Account Manager / Account Director: Competative

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Editorial Assistant Medical Education Agency: £25, 000 - £26, 000

Associate Director: £75, 000-90, 000

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Home-based Senior Project Manager – Independent Med Ed: Salary TBC

Client Services Director – Medical Education Agency – North West...: Salary TBC

Account Director – Healthcare Marketing – Berks: Salary TBC

Medical Writer: Salary TBC

Senior Account Manager: Competitive Salary Offered

Senior Account Director development role to Business Director, H...: Excellent package

Subscribe to our email news alerts

PMHub

Add my company

Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?: Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement: Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape: Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....